Document 6kOxXaJRko6kB3VjQD4e2461

RECEIVED Ml 1 * 1S82 DOW CHEMICAL U.S.A. 1803 Building 10 June 1982 MIDLAND, MICHIGAN 48640 Dr. Carol M. Stack Chemical Manufacturers Association 2501 M. Street NW Washington, DC 20037 Dear Carol, The Medical Director at each of the Dow Vinyl Chloride locations has been designated as the epidemiological contact for the Environmental Health Associates (EHA) update of the Tabershaw-Cooper study. These individuals and their addresses and phone numbers are attached. I assume the EHA has been informed that the Research Panel member for each company should receive copies of all correspondence to their company contacts since this may help expedite the collection of the data. Sincerely yours, T. R. Torkelson, Sc.D. Toxicology/Medical Liaison Health & Environmental Sciences 517/636-5197 9 cc: R. R. Cook, M.D. Director, Epidemiology, Dow Chemical U.S.A. J. R. Venable, M.D. Director, U.S. Area Medical, Dow Chemical U.S.A. Attachment HONfflDBUTIAIj AN OP1NAT1NO UNIT OP THB DOW CHIMICAL COMPANY CMA 012442 EPIDEMIOLOGICAL CONTACTS FOR THE ENVIRONMENTAL HEALTH ASSOCIATES UPDATE OF THE TABERSHAW-COOPER STUDY M. F. Currier, M.D. Medical Director, Louisiana Division Dow Chemical U.S.A. P.O. Box 150 Plaquemine, Louisiana 70764 504/389-8292 W. A. Fishbeck, M.D. Medical Director, Texas Division Dow Chemical U.S.A. Freeport, Texas 77541 713/238-3591 P. C. Gay, M.D. Medical Director, Oyster Creek Division Dow Chemical U.S.A. P.O. Box BB Freeport, Texas 77210 713/238-9633 or 9733 R. C. Kolesar, M.D. Medical Director, Michigan Division Dow Chemical U.S.A. 607 Building Midland, Michigan 48640 517/636-9765 J. M. Lanham, M.D. Medical Director Dow Chemical Canada, Inc. N7T 7K7 Sarnia, Ontario, Canada 519/339-4914 CMA 012443